 CARLSBAD, Calif., Feb. 16, 2021 GLOBE NEWSWIRE -- GenMark Diagnostics, Inc. NASDAQ: GNMK GenMark or the Company, a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Cowen 41st Annual Health Care Conference. 